Answer
Vyepti (eptinezumab) is contraindicated in patients with hypersensitivity to eptinezumab or any of the excipients listed in section 6.1.
Sources for this answer
- Vyepti 100 mg concentrate for solution for infusion (300 mg not marketed)Lundbeck Limited · emc · SmPC §4.3 Contraindications · Version 5Document updated
Sources checked